© 2003 by European Society of Cardiology
Copyright © 2003, European Society of Cardiology
Coordinated down-regulation of KCNQ1 and KCNE1 expression contributes to reduction of IKs in canine hypertrophied hearts
aCardiology, Cardiovascular Research Institute, Academic Hospital Maastricht, Maastricht, The Netherlands
bCardiology Group, Department of Molecular Biology, Masonic Medical Research Laboratory, 2150 Bleecker Street, Utica, NY 13501, USA
* Corresponding author. Tel.: +1-315-735-2217; fax: +1-315-735-5648. rdumaine{at}mmrl.edu
Received 26 March 2002; accepted 7 October 2002
| Abstract |
|---|
|
|
|---|
Objective: In animal models of hypertrophy, electrical remodeling giving rise to QT prolongation occurs rapidly and is associated with the development of torsade de pointes (TdP) arrhythmias and sudden death. Chronic AV block (CAVB)-induced hypertrophy in dogs has been associated with a reduction in the slow component (IKs) of the delayed rectifier potassium current (IK), which contributes to a prolongation of ventricular repolarization, the development of an acquired form of long QT, and the substrate for triggered activity and TdP. The present study was designed to probe the molecular basis for the decrease in IKs by studying the characteristics of KCNE1 and KCNQ1, the putative genes responsible for formation of the channel. Methods and Results: Using a combination of Northern blot, competitive multiplex PCR and immunoblot assays, we found that CAVB reduces KCNE1 and KCNQ1 RNA in the canine ventricles by 70 and 80%, respectively. Protein levels of KCNE1 and KCNQ1 were reduced by 60 and 50%, respectively. We also demonstrate at the molecular level the basis for inter-ventricular difference in IKs density previously reported in hearts of normal dogs and show the basis for reduction of this difference in the CAVB dog. Conclusions: Our results indicate that the CAVB-induced reduction in IKs is due to a down-regulation of KCNE1 and KCNQ1 transcription. The data suggest that electrical remodeling of the cardiac ventricle during hypertrophy involves regulation of the gene expression through modulation of transcriptional and translational regulatory pathways. The reduction in KCNE1 and KCNQ1 expression increases the dependence of ventricular repolarization on the rapid component of IK and may potentiate the action of Class III antiarrhythmic agents.
KEYWORDS Arrhythmia (mechanisms); Gene expression; Hypertrophy; K-channel; Long QT syndrome; Remodeling; Repolarization; Ventricular arrhythmias
| 1. Introduction |
|---|
|
|
|---|
Cardiac hypertrophy secondary to hypertension is associated with a 6-fold increase in the risk of sudden death. Prolongation of the repolarization time has been a consistent finding in hypertrophied hearts. This electrical remodeling has often been observed before fibrosis or clinical signs of heart failure become evident in animal models [1,2].
In the canine chronic atrio-ventricular block (CAVB) model, biventricular hypertrophy results from adaptation to volume overload induced by long-term bradycardia and AV asynchrony [2,3] and develops before observable changes in the tissue collagen content or capillary/fiber ratio [2]. Electrical remodeling is accompanied by the development of cellular hypertrophy [4] and predisposes the heart to the development of torsade de pointes arrhythmias [5–7]. CAVB significantly increases ventricular action potential duration (APD), more so in the left ventricle (LV) than in the right (RV), and steepens the APD–rate relationship [2]. CAVB-induced changes in repolarization are due in part to a decrease in the amplitude of the slow component of the voltage-gated delayed rectifier potassium current (IKs) [8]. In dogs with normal sinus rhythm (SR), IKs is normally larger in RV [9–12]. Reduction of IKs density during CAVB [13] may contribute to an increase in inter-ventricular and transmural dispersion of repolarization, potential indices [14] for the development of torsade de pointes [5].
The IKs channel is formed by the association of the KCNQ1 and KCNE1 gene products [15,16]; one or both are involved in LQT1, LQT5 and Jervell-Lange-Nielsen forms of congenital long QT syndrome (LQTS) [17]. The molecular basis for the inter-ventricular distribution of IKs and its reduction during CAVB is unknown. In this study we examine the hypothesis that the inter-ventricular distribution of IKs in sinus rhythm dogs and its reduction in density during CAVB are linked to altered expression of either KCNQ1, KCNE1 or both genes.
| 2. Methods |
|---|
|
|
|---|
At three time points (sinus rate, and at the idioventricular rhythm at acute and 4–6 weeks chronic AV block), a six-lead surface ECG was serially recorded together with two endocardially placed monophasic action potential catheters. To correct for the slowing of the heart rate, the anesthetised, adult mongrel dogs (20–40 kg) were paced at AAVB and CAVB at a cycle length which was comparable to the cycle length of the previous sinus rhythm. For details about placement of the MAP catheters and the analysis of the signals, we refer to previous publications [2,5].
The average area of the cardiac myocytes was obtained under brightfield microscopy by measuring the width and the length of rod shape myocytes.
Complete AV block was produced by injection of 37% formaldehyde into the AV groove. Details of the procedure were previously described [2,5]. All animals were euthanized by pentobarbital injection and the hearts were rapidly excised and placed in a cold cardioplegic solution [18]. Dogs had AV block for 102±40 days before euthanasia. Tissue or biopsies were snap frozen in liquid nitrogen and stored at –70 °C if RNA extraction or protein isolation was not immediately performed.
All procedures were performed in accordance with the Guiding Principles in the Care and Use of Animals as approved by the American Physiological Society and the Guide for the Care and Use of Laboratory Animals (NIH Publication 85-23, revised 1996) with the approval of the Committee for Experiments on Animals of Maastricht and the Masonic Medical Research Institutional Animal Care and Use Committee.
2.1 Northern blots
Transmural RV and LV biopsies from CAVB and control dogs were taken from the middle portion of each ventricle. DNA templates for the KCNQ1 (517 bp) and KCNE1 (99 bp) probes were generated from a dog cDNA library by PCR using primers with homologous sequence in human, Xenopus laevis, mouse and rat. Each amplicon was sequenced and ligated into the PCR-Script AMP SK(+) expression vector (Stratagene, Menasha, WI). The cDNA probes were then amplified by PCR and radioactively labeled by incorporation of trace amounts of [
32-P]dCTP. Total RNA was extracted using the TRIZOL Total RNA extraction kit (Gibco BRL Life Technologies, MD) according to the manufacturer's protocol. The quality and quantity of RNA were, respectively, assessed by visual inspection on denaturing gels and measured by optical density (OD) reading at 260 and 280 nm. Total RNA (20 µg/lane) was fractionated on a 1% denaturing agarose gel and transferred to a nitro-cellulose membrane (Hybond NX+, Amersham, Piscataway, NJ) for hybridization with the KCNQ1 and KCNE1 probes, respectively. Radiolabeled 18S rRNA ([
-32P]dCTP) was used as loading control. Blots were pre-hybridized (blocked) with salmon sperm ssDNA. Probes were diluted to an activity of 107 cpm/ml and allowed to hybridize on the membrane at 57–60 °C overnight. Blots were exposed to a phosphor screen for 3–4 days and analyzed on a phosphor imager (Kodak, NJ). Following analysis of the first hybridization (KCNQ1), blots were stripped and re-probed for KCNE1 RNA.
2.2 Competitive multiplex RT-PCR
Cardiac tissue (2 mg) was dissected from the base of the anterior wall of each ventricle. Total RNA was extracted as described above and reverse transcribed (RT) using Superscript II (Gibco BRL, Gaithersburg, MD) according to the manufacturer's protocol. Yields were quantified by OD260/280 and gel densitometry. A fragment of v-erB (viral erB) was amplified with composite primers having short segments of the NH3 and COOH termini of KCNE1 or KCNQ1 to yield a competitive DNA fragment (MIMIC) with terminal sequences identical to their respective target genes. MIMIC was used as an exogenous non-homologue internal standard to compete with the target genes KCNQ1 and KCNE1. MIMIC and target genes were amplified using 2 µg of RT-DNA mixed with 5 µl of MIMIC dilutions in 10-fold increments from 100 amol, Pfu DNA polymerase and dNTPs containing 0.01% of digoxigenin (DIG) labeled dTTPs. PCR products were transferred to a positively charged nylon membrane for quantitative assay. The signal was detected using FAB fragments from sheep anti-digoxigenin antibodies conjugated with alkaline phosphatase (AP) and the chemiluminescent AP substrate CDP-star (Boehringer-Mannheim, Germany). Membranes were exposed to X-ray films and the density of each band was measured using an EDC scanning densitometer (Helena Labs, Fort Worth, TX).
2.3 Cell dissociation
Cardiac myocytes were dissociated from the left ventricles of adult mongrel dogs as previously described [18]. Following dissociation, the cells were resuspended in a cardioplegic solution containing (in mM): 132 NaCl, 20 HEPES/NaOH, 3.3 MgSO4·7H2O, 11.1 D-glucose, 5 KCl, 0.5 CaCl2, 1.5% BSA and stored at 4 °C for 1–3 h. In instances where the yield of viable cells was low, the fraction was enriched by purification on a Percoll gradient as previously described [19].
2.3.1 Electrophysiological recordings
For patch clamp recordings in whole cell configuration, cells were placed in the perfusion chamber of an inverted microscope and superfused with Tyrode solution containing E-4031 (5 µM), a specific IKr blocker [20,21] and nifedipine (5 µM), a calcium channel blocker. Pipette solutions contained the following (in mM): K-aspartate 125, KCl 20, MgCl2 1, MgATP 5, HEPES 5, EGTA 10, pH 7.1 (KOH). IKs was recorded by a depolarization step to 30 mV for 3 s from a holding membrane potential of –50 mV, followed by repolarization to 0 mV (repeated five times every 10 s). Ito was not blocked, but it had little influence on our measurement of IK because of its fast and complete inactivation in this species [22]. Currents were amplified with an Axopatch 2A, recorded and analyzed using the Axon Pclamp v.8 suite of software (Axon Instruments, Carlsbad, CA).
2.4 Cryosectioning
Thin slices from the heart ventricles were dissected out and immediately placed for 10 min in a relaxing Ca-free Tyrode solution at 4 °C containing (in mM): NaCl, 130; KCl,10; CaCl, 0.2; MgCl, 2; HEPES, 10. The bathing solution was then supplemented with 5 mM caffeine and the tissue was allowed to relax for another 15 min. Tissues were then cryoprotected by incubating the slices for 4–8 h in the relaxing solution supplemented by 25% (w/v) sucrose. The slices were then quickly rinsed in Ca-free Tyrode, placed in cryogenic cassettes, dipped in liquid nitrogen for 2–4 min and stored at –80 °C. Sectioning (15 µm) of the tissue block was performed on a Leitz 1720 Digital Kryostat (Leica Microsystems, NJ) according to the manufacturer's instructions. Hematoxylin-eosin staining followed standard clinical procedures.
2.5 Immunoblots
Polyclonal antibodies (Ab) against the epitopes SVSEKSKDRGSNTIG and YIRSKKLEHSHDPFN in the COOH termini of KCNQ1 and KCNE1, respectively, were raised in rabbits by intramuscular injection of a 50:50 mixture of eight branch multiple antigenic peptides (MAP) and keyhole limpet hemocyanin (KLH) conjugated linear peptides. Abs were affinity purified on antigen Sephadex columns and their titer was determined by ELISA.
Total cell and tissue proteins were isolated out of the organic phase obtained from the total RNA isolation procedure (AMBION, Austin, TX) by sequential overnight dialysis against 0.1% SDS at 4 °C. Membrane proteins were obtained by standard sucrose gradient centrifugation. Briefly, tissues were snap frozen in liquid N2 and pulverized using a mortar and pestle. Tissue powder (1 g) was homogenized in buffer containing: HEPES (4 mM) pH 7.0, sucrose (320 mM), Pefabloc SC (0.2 mM), pepstatin A (1 µg/ml), leupeptin (1 µg/ml), aprotinin (1 µg/ml), benzamidine (100 µg/ml) and calpain inhibitors I and II (8 µg/ml each) and centrifuged at 2000xg for 10 min to remove debris. The supernatant was set aside and the pellet was resuspended in fresh buffer, re-homogenized and spun a second time at 200xg for 10 min. Both supernatants were pooled and centrifuged at 10 000xg for 1 h and the membrane protein pellet was resuspended in 1 ml buffer. Protein concentration was determined by optical density OD268:280 readings and bicinchonic acid assay (Sigma, St. Louis, MO). Proteins (20–70 µg/lane) were run on SDS–polyacrylamide (PAA) gels (12% PAA for KCNQ1; 20% PAA for KCNE1), and transferred on PVDF membranes (Bio-Rad, Hercules, CA). The blots were incubated overnight with our polyclonal antibodies (anti-KCNQ1; 1:5000) and KCNE1 (Anti-IsK; 1:500). Loading errors were controlled by comparison of the Coomassie blue or Ponceau staining of the PVDF membrane following semi-dry transfer.
The proteins of interest were detected by a secondary goat anti-rabbit Ab conjugated to alkaline phosphatase (AP) and enzymatic reaction with the chemiluminescent AP substrate CDP-Star (NEN, Boston, MA). Blots were exposed to X-ray films and each band intensity was measured using an EDC scanning densitometer (Helena Labs, Fort Worth, TX).
2.6 Statistics
Statistical significance was assessed with the Kruskal–Wallis test for non-parametric ANOVA. A level of P<0.05 was considered significant.
| 3. Results |
|---|
|
|
|---|
We initially monitored electrophysiological parameters in vivo during the adaptation of the canine heart to AV block. Fig. 1 shows that when paced at a cycle length of 600 ms, the QT interval significantly prolonged as the heart adapted (32 days of CAVB). Monophasic action potential recordings showed concomitant prolongation of LV and RV APD and revealed an average increase in inter-ventricular dispersion of repolarization from 20±15 to 45±30 ms (Table 1). With each dog serving as its own control, chronic AV block significantly increased QTc interval (limb leads) from 285±33 ms in sinus rhythm (SR) to 366±57 ms (Table 1). Structurally, the heart to body weight ratio (g/kg) increased (data±S.D.) from 7.7±1.2 (n=15) in SR [2] to 11.5±1.4 (n=10) after CAVB. Hypertrophy was also evidenced by a thickening of the left ventricle (Fig. 2), resulting from an increase in the average size of myocardial myocytes from 3381±81 µm2 (n=1166) to 4753±155 µm2 (n=387, P<0.001).
|
|
|
Previous studies [13] have shown CAVB to be associated with a reduction in IKs density in both ventricles. A similar reduction in IKs density was also observed in myocytes of our CAVB dogs (Fig. 3).
|
To link the decrease in IKs to changes in KCNQ1 and KCNE1 RNA, we performed Northern blot assays. Fig. 4A shows that our probes detected a 3.2- and 0.4-kb band corresponding to the size expected for KCNQ1 (3.2 kb) [15] and KCNE1 (0.39 kb) [23,24] RNA, respectively. In biopsies from three SR dogs, the relative intensity of the bands for KCNQ1 and KCNE1 was similar in RV and LV. CAVB decreased the KCNQ1 RNA signal by 35±10% (vs. SR) in RV and by 38±20% in LV (Fig. 4B). KCNE1 RNA was reduced by 63±8 and 46±27% (vs. SR) in LV and RV, respectively, following CAVB (Fig. 4C). We observed large inter-sample variations in the amount of transcripts within the small number of biopsies performed (n=3). We attributed part of the variation to the low sensitivity of the Northern blot assay, the inherent normalization process needed to obtain semi quantitative data and anatomical variations linked to the location of the biopsies.
|
To more accurately determine differences in mRNA, we performed multiplex RT-PCR (Fig. 5). This method was favored over RNAse protection assay because of its better reproducibility, its higher sensitivity and ability to avoid the artifactual variations inherent to comparison with housekeeping genes whose abundance may also vary during CAVB. Fig. 5D,E shows that CAVB reduced KCNE1 reverse transcribed cDNA by 72±25 and 76±29% and KCNQ1 by 82±20 and 93±7% in LV and RV, respectively (Fig. 5D,E). Multiplex RT-PCR also revealed that KCNQ1 cDNA was 355±30% more abundant in RV than in LV in SR dogs. CAVB abolished the inter-ventricular difference. In control experiments (Fig. 5B), no genomic DNA was amplified from the RNA templates.
|
To assess changes in protein expression, we performed immunoblots on proteins isolated from tissues. Fig. 6 shows that our KCNE1 antibody recognized a protein of 35 kDa and in some samples a lower molecular weight protein around 20 kDa (Fig. 6A). The density of the 35-kDa band was 23±10% higher in RV versus LV (P=0.048) of control dogs (Fig. 6B). CAVB reduced the expression of KCNE1 by 58±14 and 70±15% in LV and RV, respectively, and abolished the small inter-ventricular difference (Fig. 6B).
|
Because CAVB-induced hypertrophy may induce changes in the cellular composition of the cardiac ventricles and reduce the relative contribution of KCNQ1 and KCNE1 to the tissue protein pool, we compared the banding patterns from tissue and acutely dissociated myocyte proteins. Fig. 6C shows that a similar reduction in band intensity was observed in myocyte protein. The same observations were made in three different batches of cells from the left ventricle with an average reduction of 47±25%. In control experiments (Fig. 6D), antibodies pre-absorbed against the KCNE1 antigen failed to detect the strong 35-kDa band observed in control.
In SR dogs, our KCNQ1 Ab recognized two bands of
72 and
120 kDa. Fig. 7A shows that the intensity of both bands was strongly reduced by CAVB. To quantitate the change in expression, we measured the density of each band from the RV and LV of CAVB dogs and normalized them to their respective values in SR dogs. Fig. 7B shows that CAVB similarly reduced the density of the 72- and 120-kDa bands in LV and RV, respectively. When the intensity of both bands was averaged, protein expression was reduced by 45±10% (RV) and 60±14% (LV).
|
To assess whether the RNA distribution observed with RT-PCR translated into inter-ventricular differences in protein expression, we normalized the density of each immunoblot band from RV to its respective intensity in LV. Fig. 7C shows that significantly more KCNQ1 protein was present in the right ventricle. The RV/LV density ratio of both 72- and 120-kDa bands was greater than 1 in sinus rhythm dogs. In CAVB dogs, the RV/LV ratio of the 72-kDa band was slightly smaller but when the density of the 120- and the 72-kDa were summed the difference was not significant. Thus, CAVB significantly reduced the inter-ventricular difference in protein and RNA distribution. A 72-kDa band is predicted based on the KCNQ1 protein sequence. Fig. 7D shows that both the 72- and 120-kDa bands were recognized in the total protein preparation but only the 120-kDa band was predominant in proteins isolated from the membrane fraction. Thus, the 120-kDA band is linked to the cytoplasmic (mature) form of the protein while the 72-kDa band is likely to be related to cytosolic proteins. To verify that both bands were linked to KCNQ1, we performed immunoblots using pre-absorbed KCNQ1 antibodies. Fig. 7D (right panel) shows that the intensity of both bands was strongly reduced when the KCNQ1 antibody was pre-absorbed against the control antigen. A search for homologies in the NIH GenBank and SWISS-PROT databases revealed that the epitope recognized by the polyclonal antibody (pAb) is specific to KCNQ1. Our results show that the 72- and 120-kDa antigens contained the KCNQ1 specific epitope.
| 4. Discussion |
|---|
|
|
|---|
We show that chronic AV block induces a significant reduction in the expression of KCNE1 and KCNQ1, the putative genes responsible for IKs. The reduction in KCNE1 and KCNQ1 proteins that we report is in close agreement with the previous [13] demonstration of a 50 and 55% reduction in IKs density in the LV and RV of CAVB dogs.
KCNQ1 mRNA was 300% more abundant in RV versus LV. That inter-ventricular mRNA distribution was abolished during CAVB. Thus, our data suggest that a common transcriptional factor, possibly stabilizing mRNA, may be responsible for the inter-ventricular difference in the expression of KCNQ1 and KCNE1 and that CAVB reduces the activity of this factor.
We observed a disproportionate CAVB-induced downregulation in KCNQ1 mRNA (82–93%) when compared to protein levels (45–60%) and IKs current (50–55%). In view of its proposed role as a chaperone protein [15,16], KCNE1 may play a determining role in the expression of KCNQ1 at the level of the plasma membrane. This hypothesis is supported by our observation of a proportional reduction of KCNE1 protein, mRNA and IKs and may explain the lack of correlation with the reduction of KCNQ1 mRNA in the CAVB dog.
Our finding of a proportional reduction in the density of KCNQ1 membrane protein and cytosolic proteins, 120- and 72-kDa bands, respectively (Fig. 7B,D), also raise the interesting possibility that KCNE1 regulates the expression of KCNQ1 through a feedback mechanism coordinating the translation of KCNQ1 with the formation/recycling of the KCNQ1/KCNE1 protein complex. Although the composition of the 120-kDa band remains unclear, it is likely to be associated with a glycosylated protein complex formed by KNCQ1 and KCNE1 or another ancillary sub-unit. Our experiments with different glycosidase gave mixed results and remaining unspecific IgGs in our affinity purified polyclonal antibodies prevented efficient immunoprecipitation of KCNQ1. Commercially available KCNQ1 antibodies failed to recognize the dog epitope. Further experiments are therefore needed to fully identify the components of the 120-kDa band and validate the hypothesis of a feedback mechanism.
Previous studies have shown an up-regulation of Na+-Ca++ exchange (NCX1) current during CAVB [25]. An increase in NCX1 mRNA in models of pressure overload hypertrophy [26] was also reported. But no significant changes in the density of the transient outward current ITo1, the inward rectifier current IK1 and the slow inward calcium current were observed in our model [13,25]. Down-regulation of KCNE1 and KCNQ1 expression therefore contributes importantly to the electrical remodeling of the ventricular myocardium following volume overload hypertrophy.
Our results also provide insight into the molecular basis for the inter-ventricular difference in IKs previously shown to exist in normal hearts. We found interventricular ratios of 1.32 and 1.84 for KCNQ1 low and high molecular weight antigens, respectively. These results are are in good agreement with the data of Volders et al. [12] who reported IKs densities of 0.72±0.12 and 0.38±0.13 pA/pF for the right and left ventricle, respectively (RV/LV ratio: 1.89). This concordance between the electrophysiological and the biochemical data strengthens the notion that a KCNE1/KCNQ1 protein complex is responsible for IKs.
Recent evidence suggests that other ancillary sub-units from the KCNE family may modulate KCNQ1 expression [27,28]. However the kinetics of currents described for KCNE2/KCNQ1 or KCNE3/KCNQ1 (in heterologous systems) differ from those normally present in dog cardiomyocytes. Moreover, our data strongly suggest that the association of KCNQ1 with KCNE1 is primarily responsible for IKs and that CAVB-induced reduction of KCNE1 and KCNQ1 expression is a sufficient, but not necessarily exclusive, mechanism to account for the reduction in IKs density. Recent evidence also indicated that KCNE1 may interact with KCNH2 (HERG), the gene coding for the alpha sub-unit generating IKr [29]. Co-expression studies however demonstrated a competitive interaction between KCNE1 and KCNE2 for co-assembly with HERG largely favoring KCNE2 [29]. This observation notwithstanding, it is possible that the reduction of KCNE1 demonstrated in this study may also contribute to the marked reduction in IKr known to be associated with CAVB.
We found a molecular weight between 28 and 35 kDa for KCNE1, slightly higher than what was previously reported (25–30 kDa). We attributed the discrepancy to technical differences. The MW of KCNE1 was strongly dependent on the gel temperature and density and the protein standard used. The Bio-Rad Kaleidoscope marker, used for most of our experiments, indicated an MW around 30–35 kDa. Other markers (Promega) indicated a band closer to 29 kDa on the same gel (not shown).
4.1 Clinical implications
Prolongation of the QT interval has been a consistent finding in our model and in several other models of hypertension as well as humans. Our observations support the hypothesis that the electrical remodeling attending cardiac hypertrophy is akin to acquired long QT syndrome. The reduction of KCNQ1 and KCNE1 expression results in electrophysiology similar to the most severe form of LQTS in which IKs is drastically reduced due to dominant negative mutations in KCNQ1 or KCNE1 genes [30–33].
Torsade de pointes (TdP) commonly develops in the setting of LQTS due in part to an increased dispersion of repolarization across the ventricular wall and septum of the heart, which creates the substrate for reentry [2,14,34–36].
In the canine and human heart, M cells normally display low levels of IKs. M cells have been identified as the main culprits in LQTS-related arrhythmias because their action potentials prolong out of proportion in the presence of agents with Class III actions, thus augmenting transmural dispersion of repolarization. M cells are also prone to develop EADs as well as delayed afterdepolarizations under these same conditions [35]. The reduction in KCNE1 and KCNQ1 expression may confer to all ventricular cells arrhythmogenic properties similar to those normally found in the M region. By drastically reducing IKs, CAVB-induced hypertrophy may increase the dependence of late repolarization on IKr and, as a consequence, its sensitivity to Class III antiarrhythmic agents.
4.2 Limitations
The degree to which CAVB caused a reduction in KCNQ1 and KCNE1 RNA was smaller when assessed using Northern blot versus quantitative PCR assay. Moreover, the differences in message between RV and LV in SR dogs were less apparent using the Northern blot assay. We attribute this largely to the superior sensitivity and accuracy of the quantitative PCR versus Northern blot analysis, which relies on ratiometric measurements against an endogenous housekeeping gene RNA. These discrepancies may also be due in part to differences in the origin of the tissues along the apico-basal axis of the ventricle.
A dominant negative N-terminal truncated KVLQT1 isoform 2 lacking 129 amino acids is expressed in the human heart [37]. In immunoblots, Demolombe et al. [37] observed a small difference in the migration of the two isoforms and associated part of the weaker IKs current recorded in the left mid-myocardium to enhanced expression of the truncated isoform [38]. Our Ab against KCNQ1 could not detect bands other than those previously attributed to the long isoform of KCNQ1 [37]. The epitope recognized by our polyclonal antibody is found in human and dog KCNQ1 and is located in that part of the COOH terminal region common to both isoforms. Our immunoassays suggest that lower molecular weight isoform 2 is not present in the ventricles of the dog. In other studies (not shown), we were not able to detect RNA corresponding to the truncated isoform 2 by RT-PCR or by RACE (rapid amplification of cohesive ends) PCR on our dog cDNA library. Since isoform 2 expression is cardiac-specific through genomic imprinting [39], chromosomal variations between species may limit its expression in dog ventricles. Comparisons between species should always be made cautiously; nonetheless, our results show that isoform 1 expression is reduced during CAVB. In human, the dominant negative effect of KCNQ1 isoform 2 may add to the downregulation of KCNQ1 (isoform 1) and potentiate the reduction in IKs. Thus, our model may underestimate the reduction in IKs linked to reduced expression of KCNQ1 and KCNE1 in human.
Time for primary review 28 days.
| Acknowledgements |
|---|
This work was supported by: the Netherlands Heart Foundation, grant NHS #98042 (M.A.V.), NHS pre-doctoral funding (C.R.), US National Institutes of Health grants HL-47678 (C.A.) and HL-59449 (R.D.), and the American Heart Association, NYS Affiliate funding (C.A.).
| References |
|---|
|
|
|---|
- Kaab S., Nuss H.B., Chiamvimonvat N., et al. Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure. Circ Res (1996) 78:262–273.
[Abstract/Free Full Text] - Vos M.A., De Groot S.H., Verduyn S.C., et al. Enhanced susceptibility for acquired torsade de pointes arrhythmias in the dog with chronic, complete AV block is related to cardiac hypertrophy and electrical remodeling. Circulation (1998) 98(11):1125–1135.
[Abstract/Free Full Text] - Wusten B., Flameng W., Schaper W. Cardiac function in the chronically volume-overloaded canine heart. Basic Res Cardiol (1977) 72(2–3):172–177.[CrossRef][Web of Science][Medline]
- Verduyn S.C., Ramakers C., Snoep G., Leunissen J.D., Wellens H.J., Vos M.A. Time course of structural adaptations in chronic AV block dogs: evidence for differential ventricular remodeling. Am J Physiol Heart Circ Physiol (2001) 280(6):H2882–H2890.
[Abstract/Free Full Text] - Verduyn S.C., Vos M.A., Van der Zande J., Van der Hulst F.F., Wellens H.J. Role of interventricular dispersion of repolarization in acquired torsade-de-pointes arrhythmias: reversal by magnesium. Cardiovasc Res (1997) 34:453–463.
[Abstract/Free Full Text] - Verduyn S.C., Vos M.A., Van der Zande J., Kulcsar A., Wellens H.J. Further observations to elucidate the role of interventricular dispersion of repolarization and early afterdepolarizations in the genesis of acquired torsade de pointes arrhythmias: a comparison between almokalant and d-sotalol using the dog as its own control. J Am Coll Cardiol (1997) 30:1575–1584.[Abstract]
- Volders P.G., Sipido K.R., Vos M.A., Kulcsar A., Verduyn S.C., Wellens H.J. Cellular basis of biventricular hypertrophy and arrhythmogenesis in dogs with chronic complete atrioventricular block and acquired torsade de pointes. Circulation (1998) 98(11):1136–1147.
[Abstract/Free Full Text] - Sanguinetti M.C., Jurkiewicz N.K. Lanthanum blocks a specific component of IK and screens membrane surface charge in cardiac cells. Am J Physiol (1990) 259:H1881–H1889.[Web of Science][Medline]
- Liu D.W., Antzelevitch C. Characteristics of the delayed rectifier current (IKr and IKs) in canine ventricular epicardial, midmyocardial and endocardial myocytes: a weaker IKs contributes to the longer action potential of the M cell. Circ Res (1995) 76:351–365.
[Abstract/Free Full Text] - Salata J.J., Jurkiewicz N.K., Jow B., et al. Ik of rabbit ventricle is composed of two currents: evidence for Iks. Am J Physiol Heart Circ Physiol (1996) 271:H2477–H2489.
[Abstract/Free Full Text] - Li G.R., Feng J., Yue L., Carrier M., Nattel S. Evidence for two components of delayed rectifier K+ current in human ventricular myocytes. Circ Res (1996) 78:689–696.
[Abstract/Free Full Text] - Volders P.G., Sipido K.R., Carmeliet E., Spatjens R.L., Wellens H.J., Vos M.A. Repolarizing K+ currents ITO1 and IKs are larger in right than left canine ventricular midmyocardium. Circulation (1999) 99(2):206–210.
[Abstract/Free Full Text] - Volders P.G., Sipido K.R., Vos M.A., et al. Downregulation of delayed rectifier K(+) currents in dogs with chronic complete atrioventricular block and acquired torsades de pointes. Circulation (1999) 100(24):2455–2461.
[Abstract/Free Full Text] - Antzelevitch C, Dumaine R. Electrical heterogeneity in the heart: physiological, pharmacological and clinical implications. In: Page E, Fozzard HA, Solaro RJ (Eds.), Handbook of Physiology. The Heart. New York: Oxford University Press, Vol. 17, 2002, pp. 654–692.
- Sanguinetti M.C., Curran M.E., Zou A.R., et al. Coassembly of KvLQT1 and minK (IsK) proteins to form cardiac IKs potassium channel. Nature (1996) 384:80–83.[CrossRef][Medline]
- Barhanin J., Lesage F., Guillemare E., Fink M., Lazdunski M., Romey G. KvLQT1 and IsK (minK) proteins associate to form the IKs cardiac potassium current. Nature (1996) 384:78–80.[CrossRef][Web of Science][Medline]
- Splawski I., Shen J., Timothy K.W., et al. Spectrum of mutations in long-QT syndrome genes: KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation (2000) 102(10):1178–1185. in process citation.
[Abstract/Free Full Text] - Zygmunt A.C., Goodrow R.J., Weigel C.M. INaCa and ICl(Ca) contribute to isoproterenol-induced delayed afterdepolarizations in midmyocardial cells. Am J Physiol (1998) 275:H1979–H1992.[Web of Science][Medline]
- Heathers G.P., Yamada K.A., Kanter E.M., Corr P.B. Long-chain acylcarnitines mediate the hypoxia-induced increase in alpha-1 adrenergic receptors on adult canine myocytes. Circ Res (1987) 61:735–746.
[Abstract/Free Full Text] - Sanguinetti M.C., Jurkiewicz N.K. Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by Class III antiarrhythmic agents. J Gen Physiol (1990) 96:195–215.
[Abstract/Free Full Text] - Sanguinetti M.C., Jurkiewicz N.K. Delayed rectifier outward K+ current is composed of two currents in guinea pig atrial cells. Am J Physiol (1991) 260:H393–H399.[Web of Science][Medline]
- Liu D.W., Gintant G.A., Antzelevitch C. Ionic bases for electrophysiological distinctions among epicardial, midmyocardial, and endocardial myocytes from the free wall of the canine left ventricle. Circ Res (1993) 72:671–687.
[Abstract/Free Full Text] - Murai T., Kakizuka A., Takumi T., Ohkubo H., Nakanishi S. Molecular cloning and sequence analysis of human genomic DNA encoding a novel membrane protein which exhibits a slowly activating potassium channel activity. Biochem Biophys Res Commun (1989) 61:176–181.
- Takumi T., Ohkubo H., Nakanishi S. Cloning of a membrane protein that induces a slow voltage-gated potassium current. Science (1988) 242:1042–1045.
[Abstract/Free Full Text] - Sipido K.R., Volders P.G., De Groot S.H., et al. Enhanced Ca(2+) release and Na/Ca exchange activity in hypertrophied canine ventricular myocytes: potential link between contractile adaptation and arrhythmogenesis. Circulation (2000) 102(17):2137–2144.
[Abstract/Free Full Text] - Wang Z., Nolan B., Kutschke W., Hill J.A. Na+-Ca2+ exchanger remodeling in pressure overload cardiac hypertrophy. J Biol Chem (2001) 276(21):17706–17711.
[Abstract/Free Full Text] - Tinel N., Diochot S., Borsotto M., Lazdunski M., Barhanin J. KCNE2 confers background current characteristics to the cardiac KCNQ1 potassium channel. EMBO J (2000) 19(23):6326–6330.[CrossRef][Web of Science][Medline]
- Schroeder B.C., Waldegger S., Fehr S., et al. A constitutively open potassium channel formed by KCNQ1 and KCNE3. Nature (2000) 403(6766):196–199.[CrossRef][Medline]
- Chen J., Zou A.R., Splawski I., Keating M.T., Sanguinetti M.C. Long QT syndrome-associated mutations in the Per-Arnt-Sim (PAS) domain of HERG potassium channels accelerate channel deactivation. J Biol Chem (1999) 274:10113–10118.
[Abstract/Free Full Text] - Chen Q., Zhang D., Gingell R.L., et al. Homozygous deletion in KVLQT1 associated with Jervell and Lange-Nielsen syndrome. Circulation (1999) 99(10):1344–1347.
[Abstract/Free Full Text] - Schulze-Bahr E., Wang Q., Wedekind H., et al. KCNE1 mutations cause Jervell and Lange-Nielsen syndrome. Nat Genet (1997) 17(3):267–268.[CrossRef][Web of Science][Medline]
- Neyroud N., Tesson F., Denjoy I., et al. A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nat Genet (1997) 15(2):186–189.[CrossRef][Web of Science][Medline]
- Geelen J.L., Doevendans P.A., Jongbloed R.J., Wellens H.J., Geraedts J.P. Molecular genetics of inherited long QT syndromes. Eur Heart J (1998) 19(10):1427–1433.
[Free Full Text] - Antzelevitch C. Basic mechanisms of reentrant arrhythmias. Curr Opin Cardiol (2001) 16(1):1–7.[CrossRef][Web of Science][Medline]
- Antzelevitch C., Shimizu W., Yan G.X., et al. The M cell: its contribution to the ECG and to normal and abnormal electrical function of the heart. J Cardiovasc Electrophysiol (1999) 10(8):1124–1152.[Web of Science][Medline]
- Dumaine R., Antzelevitch C. Molecular mechanisms underlying the long QT syndrome. Curr Opin Cardiol (2002) 17(1):36–42.[CrossRef][Web of Science][Medline]
- Demolombe S., Baro I., Pereon Y., et al. A dominant negative isoform of the long QT syndrome 1 gene product. J Biol Chem (1998) 273(12):6837–6843.
[Abstract/Free Full Text] - Pereon Y., Demolombe S., Baro I., Drouin E., Charpentier F., Escande D. Differential expression of KvLQT1 isoforms across the human ventricular wall. Am J Physiol Heart Circ Physiol (2000) 278(6):H1908–H1915.
[Abstract/Free Full Text] - Lee M.P., Hu R.J., Johnson L.A., Feinberg A.P. Human KVLQT1 gene shows tissue-specific imprinting and encompasses Beckwith-Wiedemann syndrome chromosomal rearrangements. Nat Genet (1997) 15(2):181–185.[CrossRef][Web of Science][Medline]
- Van de Water A., Verheyen J., Xhonneux R., Reneman R.S. An improved method to correct the QT interval of the electrocardiogram for changes in heart rate. J Pharmacol Methods (1989) 22(3):207–217.[CrossRef][Web of Science][Medline]
This article has been cited by other articles:
![]() |
B. J.D. Boukens, V. M. Christoffels, R. Coronel, and A. F.M. Moorman Developmental Basis for Electrophysiological Heterogeneity in the Ventricular and Outflow Tract Myocardium As a Substrate for Life-Threatening Ventricular Arrhythmias Circ. Res., January 2, 2009; 104(1): 19 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Yang, Y. Lu, and Z. Wang Control of cardiac excitability by microRNAs Cardiovasc Res, September 1, 2008; 79(4): 571 - 580. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||





) corresponds to 1 kb. Size of fragments: MIMIC: 332 bp, KCNQ1: 176 bp. (B) Control experiment showing that the PCR product is not due to amplification of genomic DNA. When sterile water, total RNA or DNAse treated RNA (RNA(-DNA)) were used as template for amplification, no amplicons were observed. (C) Representative results from normal (Ctrl.) and CAVB dogs. The density of the KCNQ1 band was normalized to that of MIMIC (log {KCNQ1/MIMIC}) and plotted against the concentration of MIMIC template in each PCR tube (log [MIMIC]). A linear regression (solid line) was fitted to each set of data. (D,E) The concentration of target gene cDNA in attomoles was determined by the intersection of the linear regression with the abscissa and normalized to the amount of RT-cDNA template (mg) used in each PCR reaction. n=6 KCNE1 control dogs (Ctrl.), n=4 KCNQ1 Ctrl., n=4 CAVB dogs. Statistical significance (ANOVA): *P<0.05, **P<0.01 (Ctrl. vs. CAVB);
P<0.05 (RV vs. LV).


